FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways - Concepedia

Concepedia

Publication | Closed Access

FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways

19

Citations

13

References

2021

Year

Shiqi Wu, Shihui Huang, Qianwen Lin, Yixuan Tang, Lei Huang, Yungen Xu, Shuping Wang

Pharmacological Research

Tumor BiologySignaling PathwayPancreatic CancerMedicineTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCell SignalingCancer ResearchCancer GrowthCdc25a Signaling Pathways

References

	Year	Citations

Page 1

Page 1